Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2003
11/20/2003US20030216292 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215781 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives
11/20/2003US20030215531 Compositions and methods of use for extracts of Rutaceae plants
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003US20030214409 System and method for transparent early detection, warning, and intervention during a medical procedure
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2485753A1 Benzimidazole derivatives
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484891A1 Conjugates comprising central nervous system active drug
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003CA2484641A1 A method to improve surface properties of pharmaceutical tablets
11/20/2003CA2484398A1 Method for reducing pain using oncolytic viruses
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2483991A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362593A1 Pharmaceutical composition for diabetic neuropathy
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362589A1 The use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4- piperidinemethanol for the treatment of sleep disorders
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362586A1 Composition for the treatment of alcohol and smoking withdrawal
11/19/2003EP1362585A2 Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
11/19/2003EP1362511A1 Protective solution for preventing ischaemia
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361897A2 Methods for inhibiting pain
11/19/2003EP1361894A2 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke acting as a health protecting agent during smoking
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361888A2 Method of treating neurologcial diseases
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361879A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
11/19/2003EP1361878A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1361871A2 Medicament formulation containing a muscarinic agonist
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP1216250B1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
11/19/2003EP1216249B1 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1121107B1 Sertraline oral concentrate
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0984970B1 Spiro-quinuclidine derivatives, their preparation and use
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0796849B1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines
11/19/2003CN1456353A Senile dementia vaccinum and preparing method thereof
11/19/2003CN1456334A Preparation of Qingkailing injection
11/19/2003CN1456307A Compound fresh dendrobe tablet and preparing method thereof
11/19/2003CN1456305A Semenbiotae heart-nourishing preparation and preparing method thereof
11/19/2003CN1456290A Compound fresh dendrobe capsule and preparing method thereof
11/19/2003CN1456249A Preparation of sweet dream tablets
11/19/2003CN1456248A Preparing method for nourishing blood and tranquilization tablet
11/19/2003CN1456238A Sedative tablet preparing method
11/19/2003CN1456223A Preparation of gastrodia tuber Toufengling pills
11/19/2003CN1456199A Chinese medicinal preparation for expelling wind and removing numbness and preparing method thereof
11/19/2003CN1456197A Sobering up oral liquid
11/19/2003CN1456151A Preparing method for sustained releasing huperzine preparation
11/19/2003CN1128149C 6,9-disubsituted 2-[trans-(4-aminocyclohexyl)amino]purines
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1127981C Medicine for treating neuropathy and its preparing process
11/19/2003CN1127971C Medicine for senile dementia
11/19/2003CN1127966C 'Hehe' ointment and its preparing process
11/19/2003CN1127962C Capsule for curing hydrocephalus and its producing method
11/19/2003CN1127958C Use of baicalin flavone in treating depression
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1833